Meloxicam in combating clinical mastitis: Nanotechnology-driven hope and opportunities

Meloxicam in combating clinical mastitis: Nanotechnology-driven hope and opportunities

Mastitis has well-recognized harmful effects on dairy farm profitability. Furthermore, mastitis impairs the milk component synthesizing ability of secretary tissues. Various therapies are available for the treatment of clinical mastitis. Meloxicam exhibits preferential binding to Cyclooxygenase-2 (C...

Full description

Bibliographic Details
Main Authors: Vaskuri G S Satya Sainaga Jyothi, Chanti Katta Babu, Rahul Kumar, Pankaj Kumar Singh, Dharmendra Kumar Khatri, Shashi Bala Singh, Jitender Madan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
artificial neural network
clinical evidence
mastitis
meloxicam
preclinical evidence
topical drug delivery systems
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2022;volume=14;issue=3;spage=121;epage=125;aulast=Jyothi

Internet

http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2022;volume=14;issue=3;spage=121;epage=125;aulast=Jyothi

Similar Items